{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-16T15:28:26.285525+00:00","published_at":"2026-10-16T13:51:24.289996+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:15u6me2dbz7ig","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:51:24.289996+00:00","subject_ids":["alpha:person:jennifer-schneider","alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9"],"caused_claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:f71d7ad63d317a89a9a896279a66a7b5677513bdc42b3aedecfff0ae33710b7f"],"summary":"Jennifer Schneider seat on Vertex Pharmaceuticals, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1vmnpuaedw0m8","event_type":"COMMITTEE_CREATED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:51:24.289996+00:00","subject_ids":["alpha:committee:vertex-pharmaceuticals-inc-ma:mdcc-compensation","alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9"],"caused_claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:f71d7ad63d317a89a9a896279a66a7b5677513bdc42b3aedecfff0ae33710b7f"],"summary":"MDCC; Compensation committee of Vertex Pharmaceuticals, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1p0t2dk6rkfa0","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:51:24.289996+00:00","subject_ids":["alpha:person:jennifer-schneider","alpha:committee:vertex-pharmaceuticals-inc-ma:mdcc-compensation"],"caused_claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:f71d7ad63d317a89a9a896279a66a7b5677513bdc42b3aedecfff0ae33710b7f"],"summary":"Jennifer Schneider member of MDCC; Compensation, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:19o2wj331gke7","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-16T13:51:24.289996+00:00","subject_ids":["alpha:person:michel-lagarde","alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9"],"caused_claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:4488043de931797e682a0536afc312cae15082e3f75b3d0b6fe366f5bb05bca4"],"summary":"Michel Lagarde seat on Vertex Pharmaceuticals, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:gyd9bvy3rn9t","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-16T13:51:24.289996+00:00","subject_ids":["alpha:person:nancy-thornberry","alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9"],"caused_claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:16"],"evidence_ids":["alpha:projection-evidence:document:3d9bdbb6429f64e8b2097690ef5c293918cb8bd125d855b9b9f14945d6186a6a"],"summary":"Nancy Thornberry seat on Vertex Pharmaceuticals, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ngweg11ggmvjn","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-16T13:51:24.289996+00:00","subject_ids":["alpha:person:suketu-upadhyay","alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9"],"caused_claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:19"],"evidence_ids":["alpha:projection-evidence:document:65aa0f473458ddc2d4211d222c40e747b4e05982619bf8cfdbf0acff95ada785"],"summary":"Suketu Upadhyay seat on Vertex Pharmaceuticals, effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1de145fgl55qr","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2022-01-01","detected_at":"2026-10-16T13:51:24.289996+00:00","subject_ids":["alpha:person:suketu-upadhyay","alpha:committee:vertex-pharmaceuticals-inc-ma:audit-mdcc-compensation"],"caused_claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:19"],"evidence_ids":["alpha:projection-evidence:document:65aa0f473458ddc2d4211d222c40e747b4e05982619bf8cfdbf0acff95ada785"],"summary":"Suketu Upadhyay member of Audit; MDCC; Compensation, effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:18piqbt1l3caw9","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-16T13:51:24.289996+00:00","subject_ids":["alpha:person:diana-mckenzie","alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9"],"caused_claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:3a71ee491d4edd7ad4c444364a54a6cd98e460c73c0e4a530f213dc158d42163"],"summary":"Diana McKenzie seat on Vertex Pharmaceuticals, effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1p2ojm518sz507","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-16T13:51:24.289996+00:00","subject_ids":["alpha:person:reshma-kewalramani","alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9"],"caused_claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:17"],"evidence_ids":["alpha:projection-evidence:document:40fbba593a76c37fecbd172eaa34cbf956f7086dc717081d95a2a6812f5f78ec"],"summary":"Reshma Kewalramani seat on Vertex Pharmaceuticals, effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:g7epkx1y0ru4f","event_type":"COMMITTEE_CREATED","effective_at":"2020-01-01","detected_at":"2026-10-16T13:51:24.289996+00:00","subject_ids":["alpha:committee:vertex-pharmaceuticals-inc-ma:audit-mdcc-compensation","alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9"],"caused_claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:3a71ee491d4edd7ad4c444364a54a6cd98e460c73c0e4a530f213dc158d42163","alpha:projection-evidence:document:65aa0f473458ddc2d4211d222c40e747b4e05982619bf8cfdbf0acff95ada785"],"summary":"Audit; MDCC; Compensation committee of Vertex Pharmaceuticals, effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:celd3z15m11up","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2020-01-01","detected_at":"2026-10-16T13:51:24.289996+00:00","subject_ids":["alpha:person:diana-mckenzie","alpha:committee:vertex-pharmaceuticals-inc-ma:audit-mdcc-compensation"],"caused_claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:3a71ee491d4edd7ad4c444364a54a6cd98e460c73c0e4a530f213dc158d42163"],"summary":"Diana McKenzie member of Audit; MDCC; Compensation, effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:akg3m910gpbjz","event_type":"DIRECTOR_APPOINTED","effective_at":"2019-01-01","detected_at":"2026-10-16T13:51:24.289996+00:00","subject_ids":["alpha:person:lloyd-carney","alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9"],"caused_claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:c0e47d7c4b33b030ce488922138a8c66f509c7255719adf92e5fa78fc8a4315a"],"summary":"Lloyd Carney seat on Vertex Pharmaceuticals, effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:j2mrhb20z2iz","event_type":"COMMITTEE_CREATED","effective_at":"2019-01-01","detected_at":"2026-10-16T13:51:24.289996+00:00","subject_ids":["alpha:committee:vertex-pharmaceuticals-inc-ma:audit-cgnc-nominating-and-governance","alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9"],"caused_claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:c0e47d7c4b33b030ce488922138a8c66f509c7255719adf92e5fa78fc8a4315a"],"summary":"Audit; CGNC; Nominating and Governance committee of Vertex Pharmaceuticals, effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:eog2i61hlysqs","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2019-01-01","detected_at":"2026-10-16T13:51:24.289996+00:00","subject_ids":["alpha:person:lloyd-carney","alpha:committee:vertex-pharmaceuticals-inc-ma:audit-cgnc-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:c0e47d7c4b33b030ce488922138a8c66f509c7255719adf92e5fa78fc8a4315a"],"summary":"Lloyd Carney member of Audit; CGNC; Nominating and Governance, effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:7nes6w1cycgd6","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-16T13:51:24.289996+00:00","subject_ids":["alpha:person:alan-garber","alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9"],"caused_claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:b9e93410980e0de555ceb4e5a4d7ad206b129a10d48051765eabd6aac39769cc"],"summary":"Alan Garber seat on Vertex Pharmaceuticals, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:50ai1d1wa7xqf","event_type":"COMMITTEE_CREATED","effective_at":"2017-01-01","detected_at":"2026-10-16T13:51:24.289996+00:00","subject_ids":["alpha:committee:vertex-pharmaceuticals-inc-ma:cgnc-nominating-and-governance","alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9"],"caused_claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:b9e93410980e0de555ceb4e5a4d7ad206b129a10d48051765eabd6aac39769cc","alpha:projection-evidence:document:00cf7db9df23d437fa08d5fa748d02f566c1f00005ca782a52b7a6b0fd9dfa87"],"summary":"CGNC; Nominating and Governance committee of Vertex Pharmaceuticals, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:12cutrnv6kotd","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2017-01-01","detected_at":"2026-10-16T13:51:24.289996+00:00","subject_ids":["alpha:person:alan-garber","alpha:committee:vertex-pharmaceuticals-inc-ma:cgnc-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:b9e93410980e0de555ceb4e5a4d7ad206b129a10d48051765eabd6aac39769cc"],"summary":"Alan Garber member of CGNC; Nominating and Governance, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ksrc3z11b5s7l","event_type":"DIRECTOR_APPOINTED","effective_at":"2015-01-01","detected_at":"2026-10-16T13:51:24.289996+00:00","subject_ids":["alpha:person:sangeeta-bhatia","alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9"],"caused_claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:18"],"evidence_ids":["alpha:projection-evidence:document:00cf7db9df23d437fa08d5fa748d02f566c1f00005ca782a52b7a6b0fd9dfa87"],"summary":"Sangeeta Bhatia seat on Vertex Pharmaceuticals, effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ah28b4m13zo2","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2015-01-01","detected_at":"2026-10-16T13:51:24.289996+00:00","subject_ids":["alpha:person:sangeeta-bhatia","alpha:committee:vertex-pharmaceuticals-inc-ma:cgnc-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:18"],"evidence_ids":["alpha:projection-evidence:document:00cf7db9df23d437fa08d5fa748d02f566c1f00005ca782a52b7a6b0fd9dfa87"],"summary":"Sangeeta Bhatia member of CGNC; Nominating and Governance, effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:pqcndg1wtiigy","event_type":"DIRECTOR_APPOINTED","effective_at":"2009-01-01","detected_at":"2026-10-16T13:51:24.289996+00:00","subject_ids":["alpha:person:jeffrey-m-leiden","alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9"],"caused_claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:4204b33890421295f8e7a46549171c478894d031cbbeaf34c4d37a139f430827"],"summary":"Jeffrey M. Leiden seat on Vertex Pharmaceuticals, effective 2009-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1mq6iwi7oulnq","event_type":"BOARD_CHAIR_CHANGED","effective_at":"2009-01-01","detected_at":"2026-10-16T13:51:24.289996+00:00","subject_ids":["alpha:person:jeffrey-m-leiden","alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9"],"caused_claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:4204b33890421295f8e7a46549171c478894d031cbbeaf34c4d37a139f430827"],"summary":"Jeffrey M. Leiden chairs board Vertex Pharmaceuticals, effective 2009-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1doeq6bvs8w8x","event_type":"DIRECTOR_APPOINTED","effective_at":"1998-01-01","detected_at":"2026-10-16T13:51:24.289996+00:00","subject_ids":["alpha:person:bruce-sachs","alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9"],"caused_claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:56bd4087aac2efb2a4f1ba7b4ec47c52e892e0a1f2b3f43408a98943c5b78b94"],"summary":"Bruce Sachs seat on Vertex Pharmaceuticals, effective 1998-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:z838t3hrrg69","event_type":"LEAD_DIRECTOR_CHANGED","effective_at":"1998-01-01","detected_at":"2026-10-16T13:51:24.289996+00:00","subject_ids":["alpha:person:bruce-sachs","alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9"],"caused_claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:56bd4087aac2efb2a4f1ba7b4ec47c52e892e0a1f2b3f43408a98943c5b78b94"],"summary":"Bruce Sachs lead independent director of Vertex Pharmaceuticals, effective 1998-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:9","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jeffrey-m-leiden","object_label":"Jeffrey M. Leiden","object_source_name_forms":[],"value":"Jeffrey M. Leiden: Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jeffrey-m-leiden","name":"Jeffrey M. Leiden"},"title":"Chair","role_category":"director","committee":null,"is_board_chair":true,"is_independent":null,"start_date":"2009-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2009-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:4204b33890421295f8e7a46549171c478894d031cbbeaf34c4d37a139f430827","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:46.353365+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-03T00:00:00+00:00","effective_from":"2009-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:10","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:alan-garber","object_label":"Alan Garber","object_source_name_forms":[],"value":"Alan Garber: Director, CGNC; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:alan-garber","name":"Alan Garber"},"title":"Director","role_category":"director","committee":"CGNC; Nominating and Governance","is_board_chair":false,"is_independent":null,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:b9e93410980e0de555ceb4e5a4d7ad206b129a10d48051765eabd6aac39769cc","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:46.353365+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-03T00:00:00+00:00","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:11","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:bruce-sachs","object_label":"Bruce Sachs","object_source_name_forms":[],"value":"Bruce Sachs: Lead Independent Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:bruce-sachs","name":"Bruce Sachs"},"title":"Lead Independent Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"1998-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"1998-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:56bd4087aac2efb2a4f1ba7b4ec47c52e892e0a1f2b3f43408a98943c5b78b94","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:46.353365+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-03T00:00:00+00:00","effective_from":"1998-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:12","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:diana-mckenzie","object_label":"Diana McKenzie","object_source_name_forms":[],"value":"Diana McKenzie: Director, Audit; MDCC; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:diana-mckenzie","name":"Diana McKenzie"},"title":"Director","role_category":"director","committee":"Audit; MDCC; Compensation","is_board_chair":false,"is_independent":null,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:3a71ee491d4edd7ad4c444364a54a6cd98e460c73c0e4a530f213dc158d42163","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.05354+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-03T00:00:00+00:00","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:13","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jennifer-schneider","object_label":"Jennifer Schneider","object_source_name_forms":[],"value":"Jennifer Schneider: Director, MDCC; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jennifer-schneider","name":"Jennifer Schneider"},"title":"Director","role_category":"director","committee":"MDCC; Compensation","is_board_chair":false,"is_independent":null,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:f71d7ad63d317a89a9a896279a66a7b5677513bdc42b3aedecfff0ae33710b7f","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.446969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-03T00:00:00+00:00","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:14","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:lloyd-carney","object_label":"Lloyd Carney","object_source_name_forms":[],"value":"Lloyd Carney: Director, Audit; CGNC; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:lloyd-carney","name":"Lloyd Carney"},"title":"Director","role_category":"director","committee":"Audit; CGNC; Nominating and Governance","is_board_chair":false,"is_independent":null,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:c0e47d7c4b33b030ce488922138a8c66f509c7255719adf92e5fa78fc8a4315a","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:46.353365+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-03T00:00:00+00:00","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:15","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michel-lagarde","object_label":"Michel Lagarde","object_source_name_forms":[],"value":"Michel Lagarde: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:michel-lagarde","name":"Michel Lagarde"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":null,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:4488043de931797e682a0536afc312cae15082e3f75b3d0b6fe366f5bb05bca4","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.446969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-03T00:00:00+00:00","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:16","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:nancy-thornberry","object_label":"Nancy Thornberry","object_source_name_forms":[],"value":"Nancy Thornberry: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:nancy-thornberry","name":"Nancy Thornberry"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:3d9bdbb6429f64e8b2097690ef5c293918cb8bd125d855b9b9f14945d6186a6a","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.446969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-03T00:00:00+00:00","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:17","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:reshma-kewalramani","object_label":"Reshma Kewalramani","object_source_name_forms":[],"value":"Reshma Kewalramani: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:reshma-kewalramani","name":"Reshma Kewalramani"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:40fbba593a76c37fecbd172eaa34cbf956f7086dc717081d95a2a6812f5f78ec","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.446969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-03T00:00:00+00:00","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:18","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:sangeeta-bhatia","object_label":"Sangeeta Bhatia","object_source_name_forms":[],"value":"Sangeeta Bhatia: Director, CGNC; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:sangeeta-bhatia","name":"Sangeeta Bhatia"},"title":"Director","role_category":"director","committee":"CGNC; Nominating and Governance","is_board_chair":false,"is_independent":null,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:00cf7db9df23d437fa08d5fa748d02f566c1f00005ca782a52b7a6b0fd9dfa87","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:46.353365+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-03T00:00:00+00:00","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:19","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:suketu-upadhyay","object_label":"Suketu Upadhyay","object_source_name_forms":[],"value":"Suketu Upadhyay: Director, Audit; MDCC; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:suketu-upadhyay","name":"Suketu Upadhyay"},"title":"Director","role_category":"director","committee":"Audit; MDCC; Compensation","is_board_chair":false,"is_independent":null,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:65aa0f473458ddc2d4211d222c40e747b4e05982619bf8cfdbf0acff95ada785","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.446969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-03T00:00:00+00:00","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:4204b33890421295f8e7a46549171c478894d031cbbeaf34c4d37a139f430827","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:46.353365+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:b9e93410980e0de555ceb4e5a4d7ad206b129a10d48051765eabd6aac39769cc","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:46.353365+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:56bd4087aac2efb2a4f1ba7b4ec47c52e892e0a1f2b3f43408a98943c5b78b94","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:46.353365+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:3a71ee491d4edd7ad4c444364a54a6cd98e460c73c0e4a530f213dc158d42163","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.05354+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:f71d7ad63d317a89a9a896279a66a7b5677513bdc42b3aedecfff0ae33710b7f","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.446969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:c0e47d7c4b33b030ce488922138a8c66f509c7255719adf92e5fa78fc8a4315a","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:46.353365+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:4488043de931797e682a0536afc312cae15082e3f75b3d0b6fe366f5bb05bca4","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.446969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:3d9bdbb6429f64e8b2097690ef5c293918cb8bd125d855b9b9f14945d6186a6a","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.446969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:40fbba593a76c37fecbd172eaa34cbf956f7086dc717081d95a2a6812f5f78ec","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.446969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:00cf7db9df23d437fa08d5fa748d02f566c1f00005ca782a52b7a6b0fd9dfa87","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:46.353365+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:65aa0f473458ddc2d4211d222c40e747b4e05982619bf8cfdbf0acff95ada785","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.446969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.804,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.746,"cross_source_agreement":0.75,"temporal_completeness":0.333},"diagnostics":{"published_claims":52,"factual_claims":52,"claims_with_linked_evidence":52,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":39,"temporal_claims_with_valid_from":13,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-16T13:51:24.289996+00:00","observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":"2026-10-16T13:51:24.289996+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":52,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/vertex-pharmaceuticals-inc-ma/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}